Literature DB >> 15450677

Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer's disease in Chinese.

Binbin Wang1, Chuanfang Zhang, Weidong Zheng, Zeping Lu, Chenguang Zheng, Ze Yang, Li Wang, Feng Jin.   

Abstract

A polymorphism (T/C) in intron 2 of the cholesterol 24-hydroxylase (CYP46) gene has recently been reported to be associated with the risk for late-onset Alzheimer's disease (LOAD). To investigate possible involvement of the CYP46 gene and apolipoprotein E (APOE) gene polymorphisms in the manifestation of LOAD, we analyzed 99 sporadic LOAD patients and 113 healthy controls of China. We found an obvious association between CYP46 TT genotype and LOAD (OR = 2.98, 95% CI 1.64-5.44, P < 0.001). A clear increase of the risk to develop LOAD was also observed in subjects carrying both the CYP46 TT genotype and the APOE epsilon4-allele (OR = 12.94, 95% CI 4.26-39.32, P < 0.001). Our data reveal that the polymorphism of CYP46 intron 2 is implicated in the susceptibility to LOAD and a strong synergistic interaction between CYP46 TT homozoygots and APOE epsilon4 carrier status on the risk of LOAD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15450677     DOI: 10.1016/j.neulet.2004.07.020

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  CYP46 T/C polymorphism is not associated with Alzheimer's dementia in a population from Hungary.

Authors:  Anna Juhász; Agnes Rimanóczy; Krisztina Boda; Gábor Vincze; Gyozo Szlávik; Marianna Zana; Annamária Bjelik; Magdolna Pákáski; Nikoletta Bódi; András Palotás; Zoltán Janka; János Kálmán
Journal:  Neurochem Res       Date:  2005-08       Impact factor: 3.996

2.  An intronic CYP46A1 polymorphism is associated with Alzheimer disease in a Chinese Han population.

Authors:  Xiao-ming He; Zhen-xin Zhang; Jun-Wu Zhang; Yong-tao Zhou; Cheng-bin Wu; Mou-ni Tang; Zhen Hong
Journal:  J Mol Neurosci       Date:  2012-04-22       Impact factor: 3.444

3.  Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics.

Authors:  Ramón Cacabelos; Rocío Martínez; Lucía Fernández-Novoa; Juan C Carril; Valter Lombardi; Iván Carrera; Lola Corzo; Iván Tellado; Jerzy Leszek; Adam McKay; Masatoshi Takeda
Journal:  Int J Alzheimers Dis       Date:  2012-03-14

Review 4.  Characterizing the preclinical stages of Alzheimer's disease and the prospect of presymptomatic intervention.

Authors:  Richard J Caselli; Eric M Reiman
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 5.  CYP46A1 T/C polymorphism associated with the APOE ε4 allele increases the risk of Alzheimer's disease.

Authors:  Ling Li; Zegang Yin; Juan Liu; Gongbo Li; Yanjiang Wang; Jiachuan Yan; Huadong Zhou
Journal:  J Neurol       Date:  2012-10-16       Impact factor: 4.849

Review 6.  Cyp46 polymorphisms in Alzheimer's disease: a review.

Authors:  Anália Nusya Medeiros Garcia; Maria Tereza Cartaxo Muniz; Hugo Rafael Souza e Silva; Helker Albuquerque da Silva; Luiz Athayde-Junior
Journal:  J Mol Neurosci       Date:  2009-08-25       Impact factor: 3.444

7.  Synthesis and pharmacokinetic study of a 11C-labeled cholesterol 24-hydroxylase inhibitor using 'in-loop' [11C]CO2 fixation method.

Authors:  Zhen Chen; Jiahui Chen; Natalia Mast; Jian Rong; Xiaoyun Deng; Tuo Shao; Hualong Fu; Qingzhen Yu; Jiyun Sun; Yihan Shao; Lee Josephson; Thomas Lee Collier; Irina Pikuleva; Steven H Liang
Journal:  Bioorg Med Chem Lett       Date:  2020-03-06       Impact factor: 2.823

8.  Role of cholesterol 24S-hydroxylase gene polymorphism (rs754203) in primary open angle glaucoma.

Authors:  Georg Mossböck; Martin Weger; Christoph Faschinger; Otto Schmut; Wilfried Renner; Andreas Wedrich; Christina Zimmermann; Yosuf El-Shabrawi
Journal:  Mol Vis       Date:  2011-02-26       Impact factor: 2.367

9.  Association of angiotensin-converting enzyme, CYP46A1 genes polymorphism with senile cataract.

Authors:  Syed Tasleem Raza; Shania Abbas; Anu Chandra; Luxmi Singh; Saliha Rizvi; Farzana Mahdi
Journal:  Oman J Ophthalmol       Date:  2017 Jan-Apr
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.